$MCHX

Marchex (MCHX) Reports Q1 Loss, Misses Revenue Estimates

Marchex (MCHX) delivered earnings and revenue surprises of -100% and 4.35%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Original reporting
Zacks Commentary · Zacks Equity Research
Published May 13, 2025, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 14, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Marchex (MCHX) Reports Q1 Loss, Misses Revenue Estimates — source image
Decision brief

The 30-second read

$MCHXBearishMed
01

Why it matters

The earnings miss may lead to short-term selling pressure, but revenue growth suggests underlying demand remains.

02

Market read

The news is relevant for traders with exposure to MCHX or the tech sector; other stocks are less affected.

03

What to watch

Potential for company to implement cost-cutting measures or strategic pivots that could improve future performance.

Relevance 6/10Timing: short-term (next 1-2 weeks)

Background

Marchex reported Q1 2025 earnings with a significant loss, possibly due to operational issues or one-time charges.

Company-level read

Ticker impact

$MCHXBearishMedium confidence
Context

The company's recent quarterly earnings report indicates a significant loss and a slight revenue beat, which may influence short-term trading decisions.

Expected impact

Potential short-term decline due to earnings miss, but limited long-term impact if revenue growth sustains.

Evidence & confidence

The earnings miss is severe, but revenue growth and low relevance sentiment suggest limited immediate downside; technical levels and broader market conditions should be monitored.

Market effects

Technology sector may experience slight volatility due to earnings reports from individual companies.

Limited regional impact; primarily affects US-based stocks.

Negligible; company-specific news with limited global implications.

Counterpoint

The revenue increase, though modest, could signal resilience, and the stock might rebound if market perceives the loss as a one-time event.

Key entities

  • Marchex

    A provider of call tracking and analytics solutions.

Related articles

$MCHXMed

Marchex Announces Second Quarter 2026 Financial Results

MARCHEX INC (MCHX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Marchex Announces Second Quarter 2026 Financial Results Reports Improved Profitability and Early Momentum Following Archenia Acquisition SEATTLE, WA – August 12, 2026 – Marchex, Inc. (NASDAQ: MCHX), a vertically focused, AI-driven conversation analytics, customer acq

$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

$GNRCHigh

Amazon data centers are expected to get $2.4B in backup generators

Generac Holdings Inc. (GNRC) reported Q3 2026 net sales of $1.29B, up 16% YoY. C&I segment sales rose 28% to $552M, while residential sales increased 9% to $743M. Net income was $109M ($1.83 per share), up from $66M ($1.12 per share) in 2025. The company secured a $2.4B deal with Amazon for backup generators. Full-year 2026 net sales growth guidance remains in the mid-to-high teens percent range.